AstraZeneca: won’t profit from COVID-19 vaccine in pandemic

LONDON (AP) — Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment.